Air Products & Chemicals, Inc.: Form 10-Q for the period ended Dec 31, 2009
Filed with the SEC on Jan 26, 2010 and accepted by EDGAR at Jan 26, 2010, 16:00 ET.
Management's discussion and analysis
As filed, 25,303 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(Millions of dollars, except for share data)
The disclosures in this quarterly report are complementary to those made in the Company’s 2009 Form 10-K. An analysis of results for the first quarter of 2010 is provided in the Management’s Discussion and Analysis to follow.
All comparisons in the discussion are to the corresponding prior year unless otherwise stated. All amounts presented are in accordance with U.S. generally accepted accounting principles, except as noted. All amounts are presented in millions of dollars, except for share data, unless otherwise indicated.
Unless otherwise indicated, captions such as income from continuing operations attributable to Air Products and net income attributable to Air Products are simply referred to as “income from continuing operations” and “net income” throughout this Management’s Discussion and Analysis.
FIRST QUARTER 2010 VS. FIRST QUARTER 2009
FIRST QUARTER 2010 IN SUMMARY
- Sales of $2,173.5 declined 1%. Lower energy and raw material cost pass-through to customers due to lower natural gas prices reduced sales by 7%. This decline was partially offset by favorable currency of 4% and higher underlying sales of 2% led by volume increases in the Tonnage and Electronics and Performance Materials segments.
- Operating income of $345.0 increased $230.9 due to the prior year cost reduction charge of $174.2, higher volumes, cost improvements and favorable currency and foreign exchange.
- Income from continuing operations of $251.8 increased $161.8 and diluted earnings per share from continuing operations of $1.16 increased $.74. A summary table of changes in diluted earnings per share is presented below.
- Loss from discontinued operations in the prior year of $21.4 included an after-tax impairment charge of $30.9, or $.15 per share, and a tax benefit of $8.8, or $.04 per share, related to the U.S. Healthcare business.
20
Changes in Diluted Earnings per Share Attributable to Air Products
| Diluted Earnings per Share | Three Months Ended 31 December 2009 | 2008 | Increase (Decrease) |
|---|---|---|---|
| Net Income | $1.16 | $.32 | $.84 |
| Discontinued Operations | — | (.10) | .10 |
| Continuing Operations | $1.16 | $.42 | $.74 |
| Operating Income (after-tax) | |||
| Underlying business | |||
| Volume | .12 | ||
| Price/raw materials | (.05) | ||
| Costs | .06 | ||
| Currency | .07 | ||
| Global cost reduction plan | .55 | ||
| Operating Income | .75 | ||
| Other (after-tax) | |||
| Equity affiliate income | .01 | ||
| Interest expense | .02 | ||
| Income tax rate | (.01) | ||
| Average shares outstanding | (.03) | ||
| Other | (.01) | ||
| Total Change in Diluted Earnings per Share from Continuing Operations | $.74 |
RESULTS OF OPERATIONS
Discussion of Consolidated Results
| Three Months Ended 31 December 2009 | 2008 | % Change | |
|---|---|---|---|
| Sales | $2,173.5 | $2,195.3 | (1)% |
| Operating income | 345.0 | 114.1 | 202% |
| Equity affiliates’ income | 26.9 | 24.5 | 10% |
Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | 3% |
| Price | (1)% |
| Currency | 4% |
| Energy and raw material cost pass-through | (7)% |
| Total Consolidated Change | (1)% |
Sales of $2,173.5 decreased 1% or $21.8. Energy and raw material contractual cost pass-through to customers reduced sales by 7% due to significantly lower natural gas prices. Currency favorably impacted sales by 4%, due to the weaker U.S. dollar. Underlying business increased 2% due to higher volumes in the Tonnage and Electronics and Performance Materials segments. Volume performance in the Merchant Gases segment decreased, with declines in the U.S. and Europe more than offsetting strength in Asia.
Operating Income
Operating income of $345.0 increased $230.9.
- Underlying business increased $37, primarily from higher volumes in the Tonnage and Electronics and Performance Material segments and improved cost performance.
- Favorable currency translation and foreign exchange impacts increased operating income by $20.
- In the prior year, the global cost reduction charge reduced operating income by $174.
Equity Affiliates’ Income
Income from equity affiliates of $26.9 increased $2.4.
Selling and Administrative Expense (S&A)
S&A expense of $244.1 decreased 1%, or $2.9. S&A as a percent of sales decreased to 11.2% from 11.3%. Reduced costs, due primarily to cost reduction efforts, were offset partially by unfavorable currency.
Research and Development (R&D)
R&D expense of $27.2 decreased 18%, or $6.0, primarily due to the impact of cost reduction actions. R&D, as a percent of sales, decreased from 1.5% to 1.3%.
Global Cost Reduction Plan
In the first quarter of 2009, the results from continuing operations included a charge of $174.2 ($116.1 after-tax, or $.55 per share) for the global cost reduction plan. For additional information on this charge, as well as a subsequent charge for the plan in the third quarter of 2009, refer to the Company’s 2009 Form 10-K.
The planned actions associated with the global cost reduction plan are expected to be substantially completed within one year of when the related charges were recognized. As of 31 December 2009, the majority of the planned actions associated with the first quarter 2009 charge were completed, with the exception of certain position eliminations and/or associated benefit payments. These actions are expected to be completed in the second quarter of 2010.
Cost savings of approximately $155 are expected for 2010. Beyond 2010, the Company expects annualized savings of approximately $180, of which the majority is related to personnel costs.
Other Income, Net
Items recorded to other income arise from transactions and events not directly related to the principal income earning activities of the Company.
Other income of $11.4 increased $8.5, primarily due to foreign exchange losses in the prior year. Otherwise, no individual items were significant in comparison to the prior year.
Interest Expense
| Three Months Ended 31 December 2009 | 2008 | |
|---|---|---|
| Interest incurred | $36.4 | $41.7 |
| Less: capitalized interest | 4.8 | 5.2 |
| Interest expense | $31.6 | $36.5 |
Interest incurred decreased $5.3. The decrease was primarily driven by lower average interest rates on variable rate debt, partially offset by a higher average debt balance and the impact of a weaker dollar on the translation of foreign currency interest.
Effective Tax Rate
The effective tax rate equals the income tax provision divided by income from continuing operations before taxes less noncontrolling interests. The effective tax rate was 24.9% and 7.3% in the first quarter of 2010 and 2009, respectively. The effective tax rate was higher in 2010 as tax credits had a lower relative impact due to higher taxable income. The global cost reduction charge in 2009 significantly reduced income from continuing operations before taxes.
Discontinued Operations
In fiscal 2009, the Company completed the divestiture of its U.S. Healthcare business which has been accounted for as discontinued operations. For additional historical information on this divestiture, refer to the Company’s 2009 Form 10-K.
In the first quarter of 2009, the U.S. Healthcare business generated sales of $48.2 and income from operations, net of tax, of $.7. In addition, the Company recorded an impairment charge of $48.7 ($30.9 after-tax, or $.15 per share) reflecting a revision in the estimated net realizable value of the U.S. Healthcare business. Also, a tax benefit of $8.8, or $.04 per share, was recorded to revise the estimated tax benefit related to previously recognized impairment charges.
Net Income
Net income was $251.8 compared to $68.6. Diluted earnings per share was $1.16 compared to $.32. A summary table of changes in earnings per share is presented on page 21.
Segment Analysis
Merchant Gases
| Three Months Ended 31 December 2009 | 2008 | %Change | |
|---|---|---|---|
| Sales | $933.6 | $925.2 | 1% |
| Operating income | 189.6 | 170.5 | 11% |
| Equity affiliates’ income | 21.3 | 22.0 | (3)% |
Merchant Gases Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | (5)% |
| Price | —% |
| Currency | 6% |
| Total Merchant Gases Sales Change | 1% |
Sales of $933.6 increased 1%, or $8.4. Sales increased 6% from favorable currency effects, driven primarily by the weakening of the U.S. dollar. Volumes declined 5% due to lower demand in North America and Europe more than offsetting volume increases in Asia.
In North America, sales decreased 11%, with volumes down 9% and price down 2%. Volumes in the first two months of the prior year first quarter were relatively strong as the global economic crisis impacted volumes late in the first quarter. The price decline was due to lower surcharge activity and lower liquid hydrogen pricing. In Europe, sales increased 6%, primarily due to favorable currency impacts of 9%. Volumes unfavorably impacted sales by 4%, with price adding 1%. The unfavorable impact of the weak manufacturing environment was partially offset by increased pricing and Healthcare volumes. In Asia, sales increased 13%, with volumes up 11% and a favorable currency impact of 5%. Lower pricing decreased sales by 3%. Volumes continued to improve across Asia, driven by steel and electronics customers. The price decline is principally in liquid argon as increased capacity came on-stream in the region.
Merchant Gases Operating Income
Operating income of $189.6 increased 11%, or $19.1. The increase was primarily due to higher pricing and lower costs of $26 and favorable currency of $12, partially offset by reduced volume of $19. The improved costs were a result of global cost actions focused on workforce reduction, distribution efficiency, and reduced plant operating costs.
Tonnage Gases
| Three Months Ended 31 December 2009 | 2008 | % Change | |
|---|---|---|---|
| Sales | $697.9 | $744.0 | (6)% |
| Operating income | 100.2 | 108.8 | (8)% |
Tonnage Gases Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | 11% |
| Currency | 4% |
| Energy and raw material costs pass-through | (21)% |
| Total Tonnage Gases Sales Change | (6)% |
Sales of $697.9 decreased 6%, or $46.1. Lower energy and raw material contractual cost pass-through to customers due to lower natural gas prices reduced sales by 21%. Volumes increased 11% due to continued improvement in steel and chemical customers and new plants coming on-stream. Currency favorably impacted sales by 4%, driven primarily by the weakening of the U.S. dollar.
Tonnage Gases Operating Income
Operating income of $100.2 decreased 8%, or $8.6. The decline was a result of lower operating efficiencies and higher planned maintenance costs of $34, partially offset by increased volumes of $23 and favorable currency impacts of $2.
Electronics and Performance Materials
| Three Months Ended 31 December 2009 | 2008 | % Change | |
|---|---|---|---|
| Sales | $433.4 | $406.6 | 7% |
| Operating income | 48.4 | 24.6 | 97% |
Electronics and Performance Materials Sales
| Underlying business | % Change from Prior Year |
|---|---|
| Volume | 11% |
| Price | (6)% |
| Currency | 2% |
| Total Electronics and Performance Materials Sales Change | 7% |
Sales of $433.4 increased 7%, or $26.8, due to higher volumes of 11% and favorable currency impacts of 2%. These increases were partially offset by unfavorable pricing of 6%. Electronics sales were down 2% and were impacted by lower prices and lower services and equipment sales. Performance Materials sales increased 18%, reflecting increased demand across end markets in Asia.
Electronics and Performance Materials Operating Income
Operating income of $48.4 increased 97%, or $23.8, primarily due to improved sales volumes and reduced costs due to productivity and cost reduction efforts, partially offset by reduced pricing.
Equipment and Energy
| Three Months Ended 31 December 2009 | 2008 | %Change | |
|---|---|---|---|
| Sales | $108.6 | $119.5 | (9)% |
| Operating income | 7.8 | 7.0 | 11% |
Equipment and Energy Sales and Operating Income
Sales of $108.6 decreased 9%, or $10.9, due to lower project activity. Operating income of $7.8 increased primarily from lower energy development spending, which was partially offset by restructuring costs to close a European manufacturing facility.
The sales backlog for the Equipment business at 31 December 2009 was $327, compared to $239 at 30 September 2009.
Other
Other operating income (loss) includes expense and income that cannot be directly associated with the business segments, including foreign exchange gains and losses, interest income and costs previously allocated to businesses now reported as discontinued operations. Also included are LIFO inventory adjustments, as the business segments use FIFO and the LIFO pool adjustments are not allocated to the business segments. Corporate general and administrative costs and research and development costs are fully allocated to the business segments.
Other operating loss was $(1.0) compared to a loss of $(22.6) primarily due to unfavorable foreign exchange and an unfavorable LIFO inventory adjustment in the prior year. No other individual items were significant in comparison to the prior year.
| Three Months Ended 31 December 2009 | 2008 | |
|---|---|---|
| Operating loss | $(1.0) | $(22.6) |
PENSION BENEFITS
Refer to Note 9 to the consolidated financial statements for details on pension cost and cash contributions. For additional information on the Company’s pension benefits and associated accounting policies, refer to the Pension Benefits section of Management’s Discussion and Analysis and Note 15 to the consolidated financial statements in the Company’s 2009 Form 10-K.
LIQUIDITY AND CAPITAL RESOURCES
Cash Flow
The narrative below refers to the consolidated statements of cash flows included on page 6.
Operating Activities
Net cash provided by operating activities decreased $5.3, or 3%. The decrease resulted from unfavorable changes in working capital of $273.9, mostly offset by an increase in net income of $183.2 combined with the favorable impact of noncash adjustments to income of $85.4.
Noncash adjustments include depreciation and amortization, impairment charges, deferred income taxes, and share-based compensation cost. These adjustments also include changes in operating assets, such as noncurrent capital lease receivables, and liabilities which reflect timing differences between the receipt or disbursement of cash and their recognition in earnings.
- Net income in the current year included a noncash expense for deferred income taxes as the benefit of higher pension plan contributions and the utilization of tax benefit carry-forwards were reflected in the current provision. Net income in 2009 included noncash impairment charges of $80.8 related to the global cost reduction plan and the discontinued U.S. Healthcare business.
Changes in working capital resulted in a $273.9 negative cash flow variance and included:
- A $247.0 negative cash flow variance due to a higher use of cash for payables and accrued liabilities. This variance was due primarily to pension contributions of $255.7 in 2010 compared to $42.6 in 2009.
- A $128.7 negative cash flow variance in trade receivables. The prior year reflected a positive cash flow of $101.7 resulting from a significant drop off in sales.
- An $86.0 positive cash flow variance from other receivables due primarily to changes in derivative receivables.
Investing Activities
Cash used for investing activities decreased $29.9, due principally to changes in restricted cash of $44.9.
- Decreases in the restricted cash balances caused by project spending resulted in a source of cash of $13.2 in 2010. Prior year activity resulted in a use of cash of $31.7 as new bond proceeds exceeded project spending. The proceeds from the issuance of certain Industrial Revenue Bonds must be held in escrow until related project spending occurs and are classified as noncurrent assets in the balance sheet.
Capital expenditures are detailed in the table below.
| Three Months Ended 31 December 2009 | 2008 | |
|---|---|---|
| Additions to plant and equipment | $288.8 | $291.7 |
| Acquisitions, less cash acquired | 9.9 | 1.6 |
| Investment in and advances to unconsolidated affiliates | 3.0 | 0.1 |
| Capital expenditures on a GAAP basis | $301.7 | $293.4 |
| Capital lease expenditures (a) | 43.5 | 39.5 |
| Capital expenditures on a Non-GAAP basis | $345.2 | $332.9 |
(a) The Company utilizes a non-GAAP measure in the computation of capital expenditures and includes spending associated with facilities accounted for as capital leases. Certain contracts associated with facilities that are built to provide product to a specific customer are required to be accounted for as leases, and such spending is reflected as a use of cash within cash provided by operating activities. The presentation of this non-GAAP measure is intended to enhance the usefulness of information by providing a measure which the Company’s management uses internally to evaluate and manage the Company’s expenditures.
Financing Activities
Cash used for financing activities increased $206.6, primarily due to a net decrease in borrowings of $237.8, partially offset by higher proceeds of $26.6 from stock option exercises.
- Company borrowings (short- and long-term proceeds, net of repayments) were a net repayment of $24.5 as compared to net borrowings of $213.3 during 2009. Borrowings in 2009 included the issuance of $80.0 of Industrial Revenue Bonds and $165.8 of commercial paper.
Total debt at 31 December 2009 and 30 September 2009, expressed as a percentage of the sum of total debt and total equity, was 46.0% and 47.7%, respectively. Total debt decreased from $4,501.5 at 30 September 2009 to $4,418.7 at 31 December 2009.
The Company’s total multicurrency revolving facility, maturing in May 2011, amounted to $1,450.0 at 31 December 2009. No borrowings were outstanding under these commitments. Additional commitments totaling $449.9 are maintained by the Company’s foreign subsidiaries, of which $293.2 were utilized at 31 December 2009.
On 20 September 2007, the Board of Directors authorized the repurchase of up to $1,000 of the Company’s outstanding common stock. In the first quarter of 2010, the Company did not purchase any shares under this authorization. At 31 December 2009, $649.2 in share repurchase authorization remained.
CONTRACTUAL OBLIGATIONS
The Company is obligated to make future payments under various contracts such as debt agreements, lease agreements, unconditional purchase obligations and other long-term obligations. There have been no material changes to contractual obligations as reflected in the Management’s Discussion and Analysis in the Company’s 2009 Form 10-K.
COMMITMENTS AND CONTINGENCIES
Refer to Note 16 to the consolidated financial statements in the Company’s 2009 Form 10-K and Note 10 in this quarterly filing.
OFF-BALANCE SHEET ARRANGEMENTS
There have been no material changes to off-balance sheet arrangements as reflected in the Management’s Discussion and Analysis in the Company’s 2009 Form 10-K. The Company is not a primary beneficiary in any material variable interest entity. The Company’s off-balance sheet arrangements are not reasonably likely to have a material impact on financial condition, changes in financial condition, and results of operations or liquidity.
RELATED PARTY TRANSACTIONS
The Company’s principal related parties are equity affiliates operating in the industrial gas business. The Company did not engage in any material transactions involving related parties that included terms or other aspects that differ from those which would be negotiated at arm’s length with clearly independent parties.
MARKET RISKS AND SENSITIVITY ANALYSIS
Information on the Company’s utilization of financial instruments and an analysis of the sensitivity of these instruments to selected changes in market rates and prices is included in the Company’s 2009 Form 10-K.
There were no material changes to market risk sensitivities for interest rate risk on fixed debt, foreign currency exchange rate risk, or commodity price risk since 30 September 2009.
The net financial instrument position decreased from a liability of $4,510 at 30 September 2009 to a liability of $4,362 at 31 December 2009, primarily due to the impact of a stronger U.S. dollar on the translation of foreign currency debt and the impact of higher interest rates on the market value of long-term debt.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Management’s Discussion and Analysis of the Company’s financial condition and results of operations is based on the consolidated financial statements and accompanying notes that have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
The significant accounting policies of the Company are described in Note 1 to the consolidated financial statements and the critical accounting policies and estimates are described in the Management’s Discussion and Analysis included in the 2009 Form 10-K. Information concerning the Company’s implementation and impact of new accounting standards issued by the FASB is included in Note 2 to the consolidated financial statements. There have been no changes in accounting policy in the current period that had a material impact on the Company’s financial condition, change in financial condition, liquidity or results of operations.
NEW ACCOUNTING GUIDANCE
See Note 2 to the consolidated financial statements for information concerning the Company’s implementation and impact of new accounting guidance.
FORWARD-LOOKING STATEMENTS
This document contains “forward-looking statements” within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date this Report is filed regarding important risk factors. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors not anticipated by management, including, without limitation, longer than anticipated delay in global economic recovery; renewed deterioration in economic and business conditions; weakening demand for the Company’s products; future financial and operating performance of major customers and industries served by the Company; inability to collect receivables from or recovery of payments made by customers in bankruptcy proceedings; unanticipated contract terminations or customer cancellations or postponement of projects and sales; asset impairments due to economic conditions or specific product or customer events; costs associated with future restructuring actions which are not currently planned or anticipated; the impact of competitive products and pricing; interruption in ordinary sources of supply of raw materials; the ability to recover unanticipated increased energy and raw material costs from customers; costs and outcomes of litigation or regulatory activities; consequences of acts of war or terrorism impacting the United States and other markets; the effects of a pandemic or epidemic or a natural disaster; charges related to current portfolio management and cost reduction actions; the success of implementing cost reduction programs and achieving anticipated acquisition synergies; the timing, impact, and other uncertainties of future acquisitions or divestitures; significant fluctuations in interest rates and foreign currencies from that currently anticipated; the continued availability of capital funding sources in all of the Company’s foreign operations; the impact of new or changed environmental, healthcare, tax or other legislation and regulations in jurisdictions in which the Company and its affiliates operate; the impact of new or changed financial accounting guidance; the timing and rate at which tax credits can be utilized and other risk factors described in the Company’s Form 10-K for its fiscal year ended 30 September 2009. The Company disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this document to reflect any change in the Company’s assumptions, beliefs or expectations or any change in events, conditions, or circumstances upon which any such forward-looking statements are based.
Market risk
As filed, 161 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Refer to the Market Risks and Sensitivity Analysis on page 27 of Item 2 in Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Controls and procedures
As filed, 1,275 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We maintain a comprehensive set of disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) designed to ensure that information required to be disclosed in our filings under the Exchange Act is recorded, processed, summarized and reported accurately and within the time periods specified in the SEC’s rules and forms. As of 31 December 2009 (the Evaluation Date), an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures was carried out under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of the Evaluation Date, the design and operation of these disclosure controls and procedures were effective to provide reasonable assurance of the achievement of the objectives described above.
During the quarter that ended on the Evaluation Date, there was no change in internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2009-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2009-10-01 to 2009-12-31 | $2.17bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2009-10-01 to 2009-12-31 | $1.57bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months2009-10-01 to 2009-12-31 | $27.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2009-10-01 to 2009-12-31 | $244.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2009-10-01 to 2009-12-31 | $345.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2009-10-01 to 2009-12-31 | $31.6m | us-gaap:InterestExpense |
| Income tax | 3 months2009-10-01 to 2009-12-31 | $83.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2009-10-01 to 2009-12-31 | $251.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2009-10-01 to 2009-12-31 | $1.16 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2009-10-01 to 2009-12-31 | $1.19 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2009-10-01 to 2009-12-31 | 217,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2009-10-01 to 2009-12-31 | $193.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2009-10-01 to 2009-12-31 | $288.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2009-10-01 to 2009-12-31 | $95.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2009-12-31 | $323.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2009-12-31 | $2.78bn | us-gaap:AssetsCurrent |
| Total assets | At period end2009-12-31 | $12.91bn | us-gaap:Assets |
| Current liabilities | At period end2009-12-31 | $2.14bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2009-12-31 | $7.73bn | us-gaap:Liabilities |
| Long-term debt | At period end2009-12-31 | $3.71bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2009-12-31 | $444.5m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2009-12-31 | $269.1m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2009-12-31 | $5.03bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950123-10-005134. Last ingested by Listed: Nov 5, 2026, 11:28 ET. Listed shows no prices and gives no investment advice.